Bristol myers squibb co stock.
About Bristol-Myers Squibb Stock (NYSE:BMY) The Bristol-Myers Squibb Company is a leading global biopharmaceutical company with a long and impressive history of innovating and developing medicines that improve the lives of patients around the world. Founded in 1887 when William McLaren Bristol and John Ripley Myers purchased the Clinton ...
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level. Try it Free. Find the latest Bristol-Myers Squibb Company (BMY) stock ...Web0.31%. £57.62B. CELG.RT | Complete Bristol Myers Squibb Co. Rt stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.WebBristol-Myers Squibb Company Common Stock. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is ...WebGet the latest Bristol-Myers Squibb Co (BRM) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. BRISTOL-MYERS SQUIBB CO 0R1F Overview - Search stock, chart, recent trades, company information, trading information, company news, fundamentals.
Bristol-Myers Squibb has no non-voting common equity. At February 1, 2013, there were 1,637,354,662 shares of common stock outstanding. DOCUMENTS INCORPORATED BY REFERENCE: Portions of the Proxy Statement for the registrant’s Annual Meeting of Stockholders to be held May 1, 2013 are incorporated by reference into Part III of this Annual ...Nov 29, 2023 · 34,300. Chris Boerner. https://www.bms.com. Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, and neuroscience diseases. The company’s products include Eliquis, an ...
Advertisement Bristol-Myers Squibb Company (BMY) NYSE - NYSE Delayed Price. Currency in USD Follow 2W 10W 9M 50.10 +0.72 (+1.46%) At close: 04:00PM EST 50.14 +0.04 (+0.08%) After hours: 07:59PM...
Bristol-Myers Squibb Insiders Are Selling The Stock. Over the last three months, we've seen significant insider selling at Bristol-Myers Squibb. In total, insiders sold US$1.1m worth of shares in ...Bristol-Myers Squibb pays a dividend and tends to rise in value over time. Management has a plan to increase the growth rate in the coming years. For a business to seriously help its investors ...Discover historical prices for BMY stock on Yahoo Finance. View daily, weekly or monthly format back to when Bristol-Myers Squibb Company stock was issued. Find the latest Bristol-Myers Squibb Company (BMY) stock analysis from Seeking Alpha’s top analysts: exclusive research and insights from bulls and bears.WebAccording to our valuation model, Bristol-Myers Squibb Co's stock appears to be modestly undervalued. With a market cap of $129.80 billion, the stock's current price of $62.15 per share is below ...
Real-Time News, Market Data and Stock Quote for Bristol-Myers Squibb. ... Co-Primary Endpoints in Advanced or Metastatic Clear Cell Renal Cell Carcinoma.
68.92. 5,977,700. *Close price adjusted for splits. **Close price adjusted for splits and dividend and/or capital gain distributions. Loading more data... Discover historical prices for BMY stock on Yahoo Finance. View daily, weekly or monthly formats back to when Bristol-Myers Squibb Company stock was issued.
The next Bristol-Myers Squibb Co. dividend is expected to go ex in 1 month and to be paid in 2 months. The previous Bristol-Myers Squibb Co. dividend was 57c and it went ex 2 months ago and it was paid 1 month ago. There are typically 4 dividends per year (excluding specials), and the dividend cover is approximately 1.4.WebComplete Bristol Myers Squibb Co. stock information by Barron's. View real-time BMY stock price and news, along with industry-best analysis. See the latest Bristol-Myers Squibb Co stock price (BMY:XNYS), related news, valuation, dividends and more to help you make your investing decisions.Bristol-Myers Squibb Co’s stock is NA in 2023, NA in the previous five trading days and down 37.41% in the past year. Currently, Bristol-Myers Squibb Co’s price-earnings ratio is 12.5. Bristol-Myers Squibb Co’s trailing 12-month revenue is $44.9 billion with a 18.4% net profit margin. Year-over-year quarterly sales growth most recently ...1.82%. 1.63%. 1.76%. 3.55%. Upgrade. Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual ( 10-K) and quarterly ( 10-Q) reports submitted to the Securities and Exchange Commission (SEC). Financial ratios and metrics for Bristol-Myers Squibb Company (BMY). Includes annual, quarterly and trailing …Web
Read about Bristol-Myers Squibb Co (BMY:XNYS) stock and today's latest news and financial updates. ... Bristol-Myers Squibb Co BMY. Morningstar Rating Unlock. Stock XNYS Rating as of Nov 24, 2023.WebThe bid-ask spread can indicate a stock’s liquidity, which is how easy it is to buy and sell in the marketplace. Often, a smaller spread suggests higher liquidity, meaning more …Bristol Myers Squibb stock (NYSE: BMY) has seen a fall of 3% in a month, compared with -4% returns for the broader S&P500 index. The company reported upbeat Q4 results last month and has a solid ...WebFind the latest Bristol-Myers Squibb Company (BMY) stock analysis from Seeking Alpha’s top analysts: exclusive research and insights from bulls and bears.WebBRISTOL-MYERS SQUIBB CO 0R1F Overview - Search stock, chart, recent trades, company information, trading information, company news, fundamentals.Shares of Bristol Myers Squibb Co. sank 0.24% to $49.98 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P...Complete Bristol Myers Squibb Co. stock information by Barron's. View real-time BMY stock price and news, along with industry-best analysis.
Stock Price Forecast. The 22 analysts offering 12-month price forecasts for Bristol-Myers Squibb Co have a median target of 60.00, with a high estimate of 90.00 and a low estimate of 50.00. The ... We then take long position, expecting the price to break the pattern. My levels to trade BMY Based on 12 Wall Street analysts offering 12 month price targets for Bristol-Myers Squibb in the last 3 months. The average price target is $70.91 with a high forecast of $85.00 and a low forecast of $56.00.Web
Bristol-Myers Squibb Co Follow Share $48.90 After Hours: $49.00 (0.20%) +0.100 Closed: Nov 20, 6:58:27 PM GMT-5 · USD · NYSE · Disclaimer search Compare to Pfizer Inc. $29.98 PFE0.20% AbbVie... Valuation. On the day of the insider's recent buy, shares of Bristol-Myers Squibb Co were trading at $48.86, giving the company a market cap of $100,476.337 billion.Bristol-Myers Squibb Co Follow Share $48.90 After Hours: $49.00 (0.20%) +0.100 Closed: Nov 20, 6:58:27 PM GMT-5 · USD · NYSE · Disclaimer search Compare to Pfizer Inc. $29.98 PFE0.20% AbbVie... When did I have to buy the shares of Bristol-Myers Squibb Co to receive the previous dividend?Bristol Myers Squibb Co. analyst ratings, historical stock prices, earnings estimates & actuals. BMY updated stock price target summary. BMY - Bristol-Myers Squibb Co. Stock - Stock Price, Institutional Ownership, Shareholders (NYSE)Find out the direct holders, institutional holders and mutual fund holders for Bristol-Myers Squibb Company (BMY).Shares of Bristol Myers Squibb Co. BMY, -0.41% rose 3.31% to $52.82 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX, -0.09% ...Back to BMY Overview. The Dividend History page provides a single page to review all of the aggregated Dividend payment information. Visit our Dividend Calendar: Our partner, Quotemedia, provides ...
the closing price as reported on the New York Stock Exchange, as of the last business day of the registrant’s most recently completed second fiscal quarter was approximately $148,383,155,646. Bristol-Myers Squibb Company has no non-voting common equity. At February 1, 2022, there were 2,179,712,820 shares of common stock outstanding.
Summary. I expected Bristol-Myers Squibb Company stock to keep rising in value through 2023 and perhaps reach triple figures. Instead, the share price has fallen 5% this year as inflationary ...Web
Convert Bristol-Myers Squibb Company stocks or shares into any currency with our handy tool, and you’ll always know what you’re getting. Select a stock. Select a currency. USD. NYSE: Bristol-Myers Squibb Company ( BMY) = 48.72 USD. Provided by Alpha Vantage. Complete Bristol Myers Squibb Co. stock information by Barron's. View real-time BMY stock price and news, along with industry-best analysis. Bristol Myers Squibb (BMY-0.41%) stock was down by a noteworthy 5.4% as of 1:32 p.m. ET Monday afternoon. Bristol's share price is in retreat mode today after the company announced over the ...My levels to trade BMY Based on 12 Wall Street analysts offering 12 month price targets for Bristol-Myers Squibb in the last 3 months. The average price target is $70.91 with a high forecast of $85.00 and a low forecast of $56.00. Based on 12 Wall Street analysts offering 12 month price targets for Bristol-Myers Squibb in the last 3 months.Currently, Bristol-Myers Squibb Co’s price-earnings ratio is 12.9. Bristol-Myers Squibb Co’s trailing 12-month revenue is $44.9 billion with a 18.4% profit margin. Year-over-year quarterly sales growth most recently was -2.2%. Analysts expect adjusted earnings to reach $7.550 per share for the current fiscal year.Complete Bristol Myers Squibb Co. stock information by Barron's. View real-time BMY stock price and news, along with industry-best analysis. Bristol-Myers Squibb (NYSE:BMY) pays an annual dividend of $2.28 per share and currently has a dividend yield of 4.66%. BMY has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The company has been increasing its dividend for 14 consecutive years, indicating the company has a strong …WebBased on 17 Wall Street analysts offering 12 month price targets for Bristol-Myers Squibb in the last 3 months. The average price target is $60.69 with a ...Detailed statistics for Bristol-Myers Squibb Company (BMY) stock, including valuation metrics, financial numbers, share information and more. Skip to main content. Log In Free Trial. Home. Stocks. ... Bristol-Myers Squibb Company (BMY) NYSE: BMY · IEX Real-Time Price · USD. Add to Watchlist 50.10 +0.72 (1.46%) At …Web
Bristol-Myers Squibb (NYSE: BMY) stock is falling on Monday after a couple of updates that are weighing on BMY shares today. The first bit of news worth noting is the results from a clinical trial ...Complete Bristol Myers Squibb Co. stock information by Barron's. View real-time BMY stock price and news, along with industry-best analysis.Feb 26, 2023 · New York-based Bristol-Myers Squibb (BMY-0.41%) is among the largest pharmaceutical companies in the world. And its stock is a no-brainer buy for investors seeking reliable dividend income. It uses BSE Star MF (with Member code 11724) as transaction platform. ... All type of mutual funds are available on Groww. ATTENTION INVESTORS. 1. For Stock ...Instagram:https://instagram. goldman sachs researchbest car insurance in nj for new driversstocks in the qqqoreillys auto parts stock It uses BSE Star MF (with Member code 11724) as transaction platform. ... All type of mutual funds are available on Groww. ATTENTION INVESTORS. 1. For Stock ... walmar mexicoswing trading brokers Bristol-Myers Squibb Co BMY. Bristol-Myers Squibb Co. BMY. Morningstar Rating. Stock XNYS Rating as of Nov 22, 2023. Summary. Chart. News. Price vs Fair Value.BRISTOL-MYERS SQUIBB CO 0R1F Overview - Search stock, chart, recent trades, company information, trading information, company news, fundamentals. vanguard ultra short bond etf Real-time Price Updates for Bristol-Myers Squibb Company (BMY-N), along with buy or sell indicators, analysis, charts, historical performance, news and moreWebStock Price Forecast. The 22 analysts offering 12-month price forecasts for Bristol-Myers Squibb Co have a median target of 60.00, with a high estimate of 90.00 and a low estimate of 50.00. The ... Shares of Bristol Myers Squibb Co. BMY, -0.41% rose 3.31% to $52.82 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX, -0.09% ...